![]() |
|
|
Vol. 29, Issue 9, 1221-1228, September 2001
Eppley Institute for Research in Cancer (S.C.C., L.Z., S.S.M.) and
Departments of Biochemistry and Molecular Biology and of Pharmaceutical
Sciences (S.S.M.), University of Nebraska Medical Center, Omaha,
Nebraska; and Wadsworth Center, New York State Department of Health and
School of Public Health (X.D.), State University of New York, Albany,
New York
Methyl-n-pentylnitrosamine (MPN) is carcinogenic for
the rat esophagus. To determine organ specificity for MPN activation by
human tissues, microsomes isolated from human organs (snap-frozen <6 h
after death or removed surgically) were incubated with
[pentyl-3H]MPN, and
[3H]pentaldehyde formation was measured by
high-pressure liquid chromatography of its
2,4-dinitrophenylhydrazone using radioflow assay. With 100 µM MPN,
mean depentylation rates were 6.6 (liver), 2.9 to 3.8 (kidney, stomach,
small intestine, and colon), and 0.4 to 1.6 (esophagus, lung, and skin)
pmol of pentaldehyde/mg of protein/min. Of 14 human esophagi, four
showed relatively high depentylation rates of 3.3 to 4.1 pmol/mg/min.
Apparent Km was 80 to 160 µM
(Vmax, 3-15 pmol/mg/min) for three
esophagi, 90 to 130 (2 livers), and 1330 (1 kidney) µM. Rat tissues
showed mean depentylation rates for 100 µM MPN of 24.9 (liver), 14.5 (esophagus), 7.0 (lung), and 0.0 to 2.7 (5 other tissues) pmol/mg/min.
MPN depentylation by rat cytochrome P450 2A3 showed an apparent
Km of 8 µM
(Vmax, 70 pmol/nmol of P450/min) and was
competitively inhibited by the CYP2A inhibitor coumarin (apparent
Ki, 4 µM). Coumarin (0.4 mM) inhibited
microsomal depentylation of 100 µM MPN by 37 to 62% for human
esophagus, liver, kidney, and colon and for rat esophagus but not for
rat liver and lung. MPN depentylation by rat esophageal microsomes
increased up to 90% on adding P450 reductase. The results indicate
organ-specific MPN metabolism by rat but not human esophagus.
Nevertheless, the relatively high activity of four human esophagi might
indicate increased susceptibility of some individuals to carcinogenesis
by unsymmetrical dialkylnitrosamines.
This article has been cited by other articles:
![]() |
H Suzuki, K Iijima, A Moriya, K McElroy, G Scobie, V Fyfe, and K E L McColl Conditions for acid catalysed luminal nitrosation are maximal at the gastric cardia Gut, August 1, 2003; 52(8): 1095 - 1101. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. L. Wong, S. E. Murphy, M. Wang, and S. S. Hecht Comparative metabolism of N-nitrosopiperidine and N-nitrosopyrrolidine by rat liver and esophageal microsomes and cytochrome P450 2A3 Carcinogenesis, February 1, 2003; 24(2): 291 - 300. [Abstract] [Full Text] [PDF] |
||||